Clinical Trial Update: A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH [Phase 1]

View source ↗

Summary

This clinical trial update describes INI-822 being studied in healthy volunteers and participants with non-alcoholic steatohepatitis (NASH) or presumed NASH in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• INI-822

Snippet

Sponsor: Inipharm Australia Pty Ltd | Conditions: Non-alcoholic Steatohepatitis | Phase 1 | Status: RECRUITING